seven weeks before merck & co. pulled the arthritis drug vioxx due to increased risks , documents released thursday .
merck officials said last week its latest research showed an increased risk of heart attacks doubled for patients who took vioxx for 18 months .
with vioxx , researchers had been warning about the drug 's possible cardiovascular events , '' the fda .
dr. david graham , concluded that vioxx posed much greater risk of cardiac arrest than those on competitor celebrex .
